-
Gemini QACs: Broad-Spectrum Biocidal Design
2026-09-23
A 2024 study designed and tested 16 octenidine-inspired gemini quaternary ammonium compounds, identifying derivatives with promising antibacterial, antifungal, antibiofilm, and virucidal activity. Its structure–activity findings suggest that changing molecular polarity and architecture can shift activity and cytotoxicity, although the results remain preclinical and assay-dependent.
-
APOE, Macrophage Polarization, and PTC Progression
2026-09-23
Huo and colleagues show that APOE is associated with papillary thyroid carcinoma progression and can reshape the tumor microenvironment toward an M2-like macrophage state. By combining patient tissue analysis, K1–THP-1 co-culture experiments, pathway analysis, and xenografts, the study connects tumor-cell APOE with PI3K/Akt/NF-κB signaling and IL-10-mediated macrophage polarization.
-
Z-YVAD-FMK: Mapping Inflammatory Cell Death
2026-09-22
A translational framework for using Z-YVAD-FMK to distinguish caspase-1-dependent pyroptosis and cytokine signaling from apoptosis and necroptosis, with practical guidance for cancer, lung injury, and inflammasome studies.
-
Abiraterone Acetate in 3D Prostate Models
2026-09-22
Build more physiologically relevant prostate cancer assays by pairing a CYP17 inhibitor with patient-derived three-dimensional spheroids. This workflow separates direct androgen receptor activity inhibition from formulation, uptake, and tissue-context effects, helping researchers interpret apparently weak responses without overcalling failure.
-
Annexin V-PE Apoptosis Detection Kit: 5 Q&As
2026-09-21
This scenario-based guide explains how the Annexin V-PE Apoptosis Detection Kit, SKU K2200, can help researchers interpret phosphatidylserine externalization in live-cell experiments. It covers assay principle, compatibility, protocol control, data interpretation, and practical vendor selection for flow cytometry and fluorescence microscopy.
-
Novel Ziprasidone Impurity: Analytical Study
2026-09-21
Murkute and colleagues identified and structurally characterized a previously unreported methylene ziprasidone dimer that appeared during scale-up of ziprasidone hydrochloride synthesis. The study combines HPLC-UV surveillance, preparative isolation, high-resolution mass spectrometry, and multidimensional NMR to show how process-related impurity control can strengthen pharmaceutical quality assessment.
-
Etomoxir in Immunometabolic Assays
2026-09-20
Etomoxir enables controlled disruption of fatty acid entry into mitochondria, making it useful for whole-blood cytokine assays, cellular lipid studies, and disease-model research. This guide connects dose-aware experimental design with practical controls that distinguish CPT-1-dependent effects from DGAT activity and vehicle or toxicity artifacts.
-
PERK–JAK1–STAT3 Signaling in Disc Pyroptosis
2026-09-19
This study identifies a mechanistic link between excessive endoplasmic reticulum stress and nucleus pulposus cell pyroptosis through the PERK/eIF2α/ATF4 axis and JAK1–STAT3 signaling. Its pathway-ordering experiments clarify how ER stress may amplify inflammatory cell death in intervertebral disc degeneration and provide a framework for branch-specific validation studies.
-
Mitomycin C: DNA Damage and Apoptosis Research
2026-09-18
Mitomycin C is an antitumor antibiotic and DNA synthesis inhibitor that forms covalent DNA adducts. Its documented activity in PC3 and colon cancer models supports its use in DNA replication inhibition, apoptosis signaling research, and TRAIL-sensitization studies.
-
DGLA–ACSL4 Ferroptosis in Acute Myeloid Leukemia
2026-09-18
The reference study identifies dihomo-γ-linolenic acid (DGLA) as a lipid metabolic trigger of ferroptosis in acute myeloid leukemia (AML) cells and positions ACSL4 as a key mediator of this response. By combining targeted metabolomics, genetic perturbation, cell-based testing, and an in vivo dietary model, the work connects fatty-acid remodeling with a potentially apoptosis-independent strategy for AML research.
-
Streptavidin-Cy3: Assay Design for Biohybrid Studies
2026-09-17
Streptavidin-Cy3 enables bright, high-affinity visualization of biotinylated targets across imaging and cytometry workflows. This guide develops a distinct assay-design framework for studying deformable biohybrid microrobots, barrier penetration, and spatially resolved biological readouts.
-
Erastin Ferroptosis Workflows for Cancer Research
2026-09-17
Build reproducible ferroptosis assays with Erastin by linking cystine–glutathione depletion to lipid oxidative damage, viability loss, and rescue controls. This practical workflow also translates VDR–GPX4 findings from an acute kidney injury study into sharper assay design for cancer biology research.
-
Tropisetron Hydrochloride: Assay Guide
2026-09-16
A scenario-based guide to using Tropisetron Hydrochloride in receptor, viability, proliferation, and transporter studies. It explains how SKU B2258 supports controlled formulation, interpretation of concentration-dependent effects, and practical vendor selection.
-
Dual SMAD and Wnt Inhibition for iPSC-RGCs
2026-09-16
Chavali et al. developed a chemically defined, non-genetic method that combines dual SMAD and canonical Wnt inhibition to generate retinal ganglion cells from induced pluripotent stem cells. The approach produced reproducible retinal progenitor and RGC populations, exceeding 80% RGC purity before CD90.2-based magnetic enrichment and supporting glaucoma-oriented disease modeling.
-
Veratridine: Voltage-Gated Sodium Channel Opener
2026-09-15
Veratridine is a voltage-gated sodium channel opener that sustains membrane depolarization by impairing sodium-channel inactivation. Its defined activity supports sodium channel dynamics research, excitotoxicity studies, seizure mechanism research, and screening assays for sodium channel blockers.